Recruiting
A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
NCT06942442
- Conditions
- Clear Cell Sarcoma (CCS), HLA-A*0201 Positive Cells Present, Neoplasms, +5 more
- Locations
-
- University of Southern California - Norris Cancer Center Los Angeles, California, United States
- Memorial Sloan Kettering Cancer Center New York, United States